Physician profile
David S Almasy
NPI 1285833707
$791.06
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $79.99 · 2021: $51.49 · 2023: $274 · 2024: $89.94 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $212.83 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $154.83 | 2019-2025 | Veozah |
| Laborie Medical Technologies Corp. | $103.27 | 2023 | |
| Hologic Sales and Service, LLC | $81.95 | 2023-2025 | Fluent Fluid Management System, Affirm Prone Biopsy System, Aptima |
| Abbvie INC. | $53.74 | 2019 | |
| Intuitive Surgical, INC. | $46.74 | 2020 | |
| Merck Sharp & Dohme LLC | $37.20 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.50 | 2019-2023 | |
| Aspira Women'S Health INC | $15.91 | 2021 | |
| Exeltis, USA INC. | $14.10 | 2024 | Slynd |
| Therapeuticsmd, INC. | $13.48 | 2019 | |
| Pfizer INC. | $12.56 | 2019 | |
| Dysis Medical, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Almasy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.